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Abstract
Objective: To identify factors associated with negative direct sputum examination among African and Cambodian patients
co-infected by Mycobacterium tuberculosis and HIV.
Design: Prospective multicenter study (ANRS1260) conducted in Cambodia, Senegal and Central African Republic.
Methods: Univariate and multivariate analyses (logistic regression) were used to identify clinical and radiological features
associated with negative direct sputum examination in HIV-infected patients with positive M. tuberculosis culture on
Lowenstein-Jensen medium.
Results: Between September 2002 and December 2005, 175 co-infected patients were hospitalized with at least one
respiratory symptom and pulmonary radiographic anomaly. Acid-fast bacillus (AFB) examination was positive in sputum
samples from 110 subjects (63%) and negative in 65 patients (37%). Most patients were at an advanced stage of HIV disease
(92% at stage III or IV of the WHO classification) with a median CD4 cell count of 36/mm
3. In this context, we found that
sputum AFB negativity was more frequent in co-infected subjects with associated respiratory tract infections (OR=2.8
[95%CI:1.1–7.0]), dyspnea (OR=2.5 [95%CI:1.1–5.6]), and localized interstitial opacities (OR=3.1 [95%CI:1.3–7.6]), but was
less frequent with CD4#50/mm
3 (OR=0.4 [95%CI:0.2–0.90), adenopathies (OR=0.4 [95%CI:0.2–0.93]) and cavitation
(OR=0.1 [95%CI:0.03–0.6]).
Conclusions: One novel finding of this study is the association between concomitant respiratory tract infection and
negative sputum AFB, particularly in Cambodia. This finding suggests that repeating AFB testing in AFB-negative patients
should be conducted when broad spectrum antibiotic treatment does not lead to complete recovery from respiratory
symptoms. In HIV-infected patients with a CD4 cell count below 50/mm3 without an identified cause of pneumonia,
systematic AFB direct sputum examination is justified because of atypical clinical features (without cavitation) and high
pulmonary mycobacterial burden.
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Introduction
M. tuberculosis/HIV co-infection is a major public health issue in
developing countries. Although most co-infections occur in sub-
Saharan Africa [1], [2], the number of co-infected patients has
increased considerably in South-East Asia [1], [3]. In populations
with a high prevalence of HIV infection, tuberculosis is a major
cause of morbidity and mortality [1], particularly in Africa [4] and
Asia [5]. Finally, tuberculosis, by facilitating HIV replication,
accelerates progression to AIDS [6].
The immunosuppression induced by HIV infection increases
the risk of developing tuberculosis [7]. In addition, the clinical
expression of tuberculosis is modified in patients with severe
immunodepression [1], [6]. Tuberculosis is generally easier to
diagnose early in the course of HIV infection, owing to its classical
expression (such as cavitation), and AFB examination is therefore
routinely performed. In the later stages of HIV disease, clinical
signs are more varied because of unusual clinical and radiological
features. As a result, AFB examination is often delayed, and
sputum smears may be negative particularly in patients without
cavitation [1], [8]. In patients with severe immunosuppression, the
mycobacterial burden may be very high and disseminated. For this
reason, Mycobacterium tuberculosis can be found in sputum,
blood and others organs (Brenda E. Jones et al [9]).
PLoS ONE | www.plosone.org 1 June 2011 | Volume 6 | Issue 6 | e21212The reference diagnostic method for pulmonary tuberculosis is
culture of Mycobacterium tuberculosis (MT) on specific Lowenstein-
Jensen medium. However, culture is rarely available in developing
countries and takes between 6 and 8 weeks, limiting its use to a
second-line diagnostic examination [10]. Direct examination of
sputum for the presence of AFB is currently the most useful
diagnostic tool, since it is simple, rapid, cheap and highly specific
[11], [12]. Unfortunately, its sensitivity is highly variable,
especially in patients with AIDS [12].
AFB-negative tuberculosis is less of a public health problem [10]
because it is less contagious, even though this form of tuberculosis is
still responsible for 15 to 20% of cases of human-human
transmission [13]. In individual patients coinfected by HIV, AFB-
negative tuberculosis is associated with a high mortality rate,
because of delayed access to antituberculous treatment and the high
degree of underlying immunodepression [14]. Thus, AFB-negative
patients pose a therapeutic dilemma: deciding to treat on clinical
grounds alone may mask the real cause of clinical manifestations,
carries a risk of unnecessary toxicity and can interfere with
antiretroviral therapy [2], [15], yet failure to treat carries a risk of
death from tuberculosis and of persistent infectivity [13].
Several studies have identified factors predictive of tuberculosis
in AFB-negative HIV-infected patients [16], [17], [18], [19].
However, few have focused on clinical and radiological charac-
teristics associated with AFB negativity in coinfected patients [20],
[21], and few have included in-depth search for etiological agents
of respiratory symptoms by means of bronchio-alveolar lavage
(BAL). Furthermore, the epidemiological context differs from
country to country, and predictive factors can also vary.
The aim of this work was to identify factors associated with
negative AFB direct sputum examination among African and
Cambodian patients coinfected by M. tuberculosis and HIV.
Methods
Study population
Data were collected as part of a multicenter study (ANRS1260)
conducted in Africa (Senegal and Central African Republic (CAR)
and Southeast Asia (Cambodia and Vietnam). This prospective
study was principally designed to document the clinical and
radiological manifestations and etiologies of pulmonary disease in
HIV-infected patients with AFB-negative on direct sputum
examination [22]. The data collection and laboratory methods
are described in detail in the princeps article [22]. This study was
approved by the Senegal Health Research National Council, the
National Ethics Committee for Health Research in Cambodia,
and Scientific Committee responsible for validation protocols and
study results in Central African Republic.
Between September 2002 and December 2005, patients were
enrolled in this study, with their written consent, if they were HIV-
infected, at least 18 years old, and had at least one respiratory
symptom (cough with or without expectoration, chest pain,
haemoptysis and/or dyspnea) and at least one radiological
pulmonary abnormality (diffuse or localized opacities, cavitation,
and/or mediastinal adenopathies).
In Senegal and Cambodia, all HIV-infected patients entered an
antiretroviral program. In CAR, however, antiretroviral treatment
was not available.
This analysis focused on subjects recruited in Cambodia,
Senegal and Central African Republic, where patient manage-
ment and data collection were the same for patients with positive
and negative direct sputum examination [22].
According to the protocol [22], three sputum samples for AFB
detection were collected before further invasive investigations,
unless invasive methods were immediately necessary because of
severe lung disease. As a result, a single sputum sample was
collected from most Cambodian patients, whose initial lung
disease tended to be more severe, while two or three samples were
collected from African patients. Cambodian patients underwent
earlier BAL than African patients for the following reasons:
severity of hypoxemia, high frequency of diffuse opacities, failure
of antibiotic treatment and high frequency of pneumocystis jiroveci.
Data collection
The following data were analyzed: i) general characteristics (age,
sex, country) and clinical features (body mass index (BMI) (kg/m
2),
headache, diarrhea, dyspnea, hemoptysis, cough duration, stage of
HIV infection (WHO classification), history of tuberculosis and
prophylaxis with trimethoprim-sulfamethoxazole (TMP-SMX) .1
month), ii) biological data (CD4 lymphocyte count, AFB detection
in sputum by direct examination and culture, results of BAL
microbiological examination), anemia (hemoglobin ,13 g/dl in
men and ,12 g/dl in women) and prior knowledge of HIV
serostatus. The chest radiographs were examined by local
physicians and by experts, as described in the princeps article
[20]. Localized opacities were recorded as interstitial or alveolar.
Blinded to the microbiological and clinical findings, two French
experts in pulmonary medicine read the radiographs. In case of
disagreement, the local physicians and the experts reached a
consensus.
Definition of definite pulmonary tuberculosis
Culture on Lowenstein-Jensen medium is the reference method.
Thus, patients in whom M. tuberculosis was isolated by culture in
sputum, bronchial fibroaspiration products or BAL fluid were
considered to have definite pulmonary tuberculosis.
Tuberculosis was ruled out only when none of respiratory
samples were culture positive.
This analysis focuses solely on patients with definite (culture-
positive) tuberculosis. Among these patients, all those with at least
one positive sputum sample on direct examination were
considered AFB-positive and all subjects in whom all sputum
samples (one to three) were negative by direct examination were
considered AFB-negative.
Definition of definite bacterial, parasitic, or yeast lung co-
infection
(a) Pneumocystis jiroveci pneumonia (PCP): the presence of the
pathogen in induced sputum or BAL fluid.
(b) Fungal pneumonia: positive direct examination and/or
culture of fiberoptic specimen and a compatible clinical
outcome.
(c) Bacterial pneumonia: positive blood culture or positive
culture of pyogenic bacteria from pleural effusion or positive
quantitative culture of a fiberoptic specimen with validated
cutoffs [$10
5CFU/ml (bronchial aspirate) or $10
4CFU/ml
(BAL)] and a compatible clinical outcome.
(d) Pneumonia due to atypical mycobacteria: positive culture of
fiberoptic specimen and no other pathogens isolated, and a
compatible clinical outcome.
(e) Pulmonary strongyloidosis: Strongyloides stercoralis larvae in
fiberoptic specimen and no other pathogens, and a
compatible clinical outcome
Research on associated respiratory tract infections was con-
ducted in all patients, even if investigative methods differed.
Tuberculosis in HIV-Infected Patients
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Positive quantitative culture of pyogenic bacteria from sputum,
with validated cutoff ($10
7 CFU/ml) and a compatible clinical
outcome; or positive quantitative culture of pyogenic bacteria from
fibroaspirate or BAL specimen, without validated cutoffs but with
a compatible clinical outcome.
Statistical methods
The patients’ characteristics were analyzed as medians and
interquartile range (IQR) for continuous variables and percent-
ages for discrete variables. Univariate analysis was based on the
Chi2 test or Fisher’s exact test for discrete variables. Continuous
variables were compared by analysis of variance or Student’s t
test if the distribution was normal, and otherwise with the
Kruskal-Wallis or Mann and Whitney test. For multivariate
analysis, quantitative variables were categorized around the
median or the clinical threshold (SaO2, CD4 cell count, and
cough duration).
All baseline variables associated with AFB-negative tubercu-
losis in univariate analysis (p ,0.25) were included in a
backward stepwise logistic regression model. Interactions be-
tween factors associated with AFB negativity and the participat-
ing region (Cambodia and the two African countries) were
tested. In order to account for the specificities of each region, the
factor ‘‘region’’ was retained in the final model, even though it
was not significant. The likelihood ratio method was used for
significance testing. A p value of ,0.05 was considered to denote
statistical significance. Multiple imputations for the CD4 cell
count missing values were performed by using variables from
logistic regression model (country, radiological characteristics
(mediastinal adenopathies, cavitation and localized interstitial)
and clinical characteristics (dyspnea and more than one
pathogen)).
Data were analyzed with STATA software version 11.0 (Stata
Corporation, College Station, Texas).
Results
Description of the population
Between September 2002 and December 2005, 175 HIV-
infected patients with definite tuberculosis were included in this
analysis (Fig. 1); 110 patients (63%) were AFB+ and 65 (37%) were
AFB-. Owing to the severity of the pulmonary disease, AFB was
performed in only one sputum sample in 93% of patients in
Cambodia, compared to 12% and 3% of patients in Senegal and
CAR.
Most cases of AFB-positive tuberculosis (89%) were diagnosed
on the first sputum sample, including in Africa (79%), where three
samples per patient were routinely examined.
Fiberoptic bronchoscopy with BAL was performed in 76
patients. Few cases of AFB-positive (n=26, 24%) tuberculosis
underwent bronchial fibroaspiration or BAL compared to AFB-
negative patients (n=50, 77%).
The main characteristics of the study population are summa-
rized in table 1. Most patients were young adults (median age 34
years), with anemia (98%, median hemoglobin level 7.6 g/dl (6.2–
9.4)), advanced stage of HIV disease (92% were at stage III (64%)
or IV (28%) of the WHO classification), and a very low median
BMI (16.9 kg/m
2 (14.9–18.8)). The median CD4 cell count was
36/mm3, and 58% of the population had counts below 50 CD4/
mm3, reflecting severe immunosuppression. Less than half the
patients (43%) were aware of their HIV serostatus before
enrollment. Of these, 14% had been on antiretroviral therapy
for more than 15 days and 26% had been taking TMP-SMZ
prophylaxis for more than a month. Few had a history of
tuberculosis (14%). Most patients (85%) received empirical
treatment.
In 15% of cases, one or more other pathogens were found in a
valid sample (78% from fibroaspirate or BAL specimen and 22%
from sputum), in addition to M. tuberculosis. In the 14 Cambodian
patients concerned, the pathogens were Pneumocystis jiroveci (n=6),
Staphylococcus aureus (n=2), Pseudomonas aeruginosa (n=2), Streptococcus
pneumoniae (n=1), Escherichia coli (n=1), Strongyloides stercoralis (n=2)
and/or Cryptococcus neoformans (n=2). In the 13 African patients
concerned, the pathogens were Staphylococcus aureus (n=5),
Pseudomonas aeruginosa (n=3), Streptococcus pneumoniae (n=3), Klebsiella
pneumoniae (n=2), Cryptococcus neoformans (n=1) and/or Mycobacte-
rium intracellulare (n=1).
Cambodian patients differed significantly from African patients,
with more frequent antibiotic therapy before hospital admission
(78% in Cambodia, 27% and 33% in Senegal and CAR), more
frequent WHO stage IV HIV infection (43% in Cambodia, 17%
in CAR and 0% in Senegal), a higher median hemoglobin level
(8.1 (6.5–10.1) g/dl in Cambodia, 7.0 g/dl (5.6–7.7) in Senegal),
and lower oxygen saturation (92% (90–96) in Cambodia versus
96% (92–98) in CAR and 98% (97–99) in Senegal).
The median CD4 cell count was higher in CAR than in the
other two countries (177/mm
3 (56–349) in CAR, 18/mm
3 (6–43)
in Cambodia and 36/mm
3 (16–66) in Senegal). Fewer patients in
CAR were aware of their HIV serostatus (12%, compared to 56%
and 64% in Senegal and Cambodia).
Univariate analysis
Table 2 shows the results of univariate analysis comparing
general, clinical, biological and radiological characteristics be-
tween AFB+ and AFB- patients.
AFB negativity was more likely in patients with localized
interstitial radiological anomalies (OR=3.1 [95%CI:1.4–7]) and
intercurrent bacterial or parasitic infections (OR=2.5[95%CI:1.1–
5.6]). In contrast, CD4 cell counts #50/mm
3 (OR=0.4 [95%-
CI:0.2–0.8]), adenopathies (OR=0.54 [95%CI:0.3–1]), cavitation
(OR=0.16 [95%CI:0.04–0.7]) and retraction (OR=0.10 [95%-
CI:0–0.6]) were associated with a lower risk of AFB negativity.
Figure 1. Distribution of AFB-positive and AFB-negative
patients with definite tuberculosis in Cambodia and Africa.
doi:10.1371/journal.pone.0021212.g001
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Threefactorswereindependentlyassociated withAFBnegativity,
namely dyspnea (OR=2.5 [95%CI:1.1–5.6]), localized interstitial
radiological abnormalities (OR=3.1 [95%CI:1.3–7.6]) and inter-
current bacterial or parasitic infections (OR=2.8 [95%CI:1.1–
7.0]). Three factors were independently associated with a lower risk
of AFB negativity, namely adenopathies (OR=0.4 [95%CI: 0.2–
0.93]), cavitation (OR=0.1 [95%CI: 0.03–0.6]) and CD4 fewer
than 50 /mm
3 (OR=0.4 [95%CI:0.2–0.90]) (Table 2). The
findings remain consistent with a multivariate model that does not
account for multiple imputations.
Given the large differences between the Cambodian and African
patients, the same analysis was repeated separately in the two
subpopulations. Different risk factors were identified. In Cambodia,
three factors were independently associated with a higher risk of
AFB negativity, namely dyspnea (OR=6.5 [95%CI:1.2–34.9]),
localized interstitial radiological abnormalities (OR=7.5 [95%CI:
2.2–25.9]) and intercurrent bacterial, fungal or parasitic infections
(OR=3.8 [95%CI:0.95–15.4]), and none was independently
associated with a lower risk of AFB negativity. In Africa, none
was independently associated with a higher risk of AFB negativity
but two factors were independently associated with a lower risk of
AFB negativity, namely cavitation (OR=0.08 [95%CI: 0.01–0.72])
and cough lasting $21 days (OR=0.3 [95%CI:0.13–0.86]).
Discussion
The patients analyzed here were all enrolled in the ANRS 1260
study. All had HIV infection and definite pulmonary tuberculosis.
Our study compared clinical and radiological features in a
significant number of HIV-coinfected AFB+ and AFB- patients
with tuberculosis. Most patients were in an advanced stage of HIV
disease (92% were at stage III or IV of the WHO classification)
with a median CD4 cell count of 36/mm
3, reflecting severe
immunosuppression. In this context, we found that sputum AFB
negativity was more frequent in co-infected subjects with dyspnea,
localized interstitial opacities, an intercurrent bacterial, fungal or
parasitic respiratory tract infection, with CD4 .50/mm
3,n o
adenopathies and no cavitation. Analyses by region showed that
associations were going in the same direction for all the factors
statistically significant in the final model. However, due to
limitation of power, only dyspnea, localized interstitial opacities,
and intercurrent respiratory tract infection were statistically
significant in Cambodia, whereas only absence of cavitation was
statistically significant in Africa. Whether these latter findings
reflect differences by region, or random fluctuations, cannot be
tested formally due to the lack of power. These diverse results
probably reflect the highly variable radiological and clinical
expression, as well as the intrapulmonary mycobacterial burden,
all of which depend on the degree of immunodepression. Indeed,
severely immunodepressed patients often have unusual clinical and
radiological features, such as more discreet cough, normal chest X
ray, miliary opacities or diffuse infiltrate, no cavitation, frequent
mediastinal adenopathies and pleuritis, a high bacillary burden,
and frequent association with another respiratory tract infection
[1], [8]. Our findings underscore that AFB-negative tuberculosis in
HIV-infected patients can be associated with less-clearcut
Table 1. Baseline characteristics of the study population.
Parameter, n (%) Cambodia Senegal
Central African
Republic All p value*
N=84 N=25 N=66 N=175
Number of subjects (% males) 57 (68) 12 (48) 22 (33) 91 (52) ,0.001
Age (years)** 34 (29–42) 36 (33–41) 32 (27–39) 34 (28–41) 0.084
Number of AFB-negative subjects 27 (32) 9 (36) 29 (44) 65 (37) 0.33
AFB+ on the 0.002
1st sputum sample 56 (98) 11 (69) 31 (84) 98 (89)
2
nd or 3
rd sputum sample 1 (2) 5 (31) 6 (16) 12 (11)
Antibiotics before admission, Yes 35 (78) 6 (27) 22 (33) 63 (47) ,0.001
Body Mass Index (BMI)** (kg/m
2) 17.0 (14.8–18.8) 16.6 (14.2–18.7) 16.7 (15.4–18.4) 16.9 (14.9–18.8) 0.75
AIDS classification (WHO) ,0.001
Stage II 1 (1) 6 (27) 6 (10) 13 (8)
Stage III 47 (56) 16 (73) 44 (73) 107 (64)
Stage IV 36 (43) 0 (0) 10 (17) 46 (28)
CD4 cell count (/mm
3)** 18 (6–43) 36 (16–66) 177 (56–349) 36 (12–145) ,0.001
Hemoglobin (g/dl) ** 8.1 (6.5–10.1) 7 (5.6–7.7) 7.5 (6–9.4) 7.6 (6.2–9.4) 0.044
Anemia, Yes 78 (98) 24 (96) 58 (98) 160 (98) 0.65
Resting oxygen saturation (SaO
2) ** 92 (90–96) 98 (97–99) 96 (92–98) 94 (90–97) ,0.001
Known HIV serostatus on admission, Yes 54 (64) 14 (56) 8 (12) 76 (43) ,0.001
- ARV for .15 days 8/54 (15) 2/14 (14) 1/8 (13) 11/76 (14) 0.99
- TMP-SMZ prophylaxis for .30 days 15/54 (28) 1/14 (7) 4/8 (50) 20/76 (26) 0.065
History of tuberculosis, Yes 13 (16) 2 (8) 9 (14) 24 (14) 0.62
More than one pathogen, Yes 14 (17) 4 (16) 9 (14) 27 (15) 0.88
*Global comparison among the three countries.
**Median (Q1, Q3).
doi:10.1371/journal.pone.0021212.t001
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PCP, ii) the absence of mediastinal adenopathies (depriving the
clinician of a major radiological sign suggestive of tuberculosis) and
iii) symptoms or signs resulting of intercurrent respiratory tract
infection (with the risk of failing to recognize associated
tuberculosis in the absence of unexplained atypical clinical data
or clinical progression despite adequate treatment).
The CD4 cell count plays an important role in the clinical
manifestations of tuberculosis in HIV-infected patients. Some
studies have reported that sputum smears are frequently negative
for AFB in patients with advanced HIV disease [1], [8].
Conversely, a CD4 cell count below 50/mm
3 was more common
in our study in patients with AFB positivity than in patients with
AFB negativity. This finding, which concurs with other studies and
particularly with Brenda E. Jones et al.’s study [9], can be
explained by the increased degree of intrapulmonary mycobacte-
rial burden in parallel with the degree of immunosuppression. In
our study, the vast majority of AFB-negative cavitation observed in
patients with advanced immunosuppression results from necrotiz-
ing bacterial infections, not from tuberculosis.
One of the most interesting findings of the study is the negativity
of AFB in the presence of bacterial, parasitic, or fungal lung co-
infection. This finding remained statistically significant in
multivariate analysis, suggesting that it is independent of potential
confounding variables such as the level of immunosuppression.
One may speculate that the presence of other infectious agents
may inhibit the production of mycobacteria.
Another hypothesis could be that co-infected patients are less
likely to produce sputum positive because they have more severe
clinical symptoms, such as dyspnea or high fever.
Interestingly, this finding may have important implications for
the management of HIV-infected patients who are AFB-negative
but who nevertheless have symptoms suggestive of tuberculosis.
Indeed, current WHO guidelines suggest that such patients be
treated with two weeks of first-line antibiotics to rule out bacterial
infection. In patients who have both tuberculosis and bacterial
lung infections, this short antibiotic treatment would lead to
immediate improvement, because of its overall efficacy against
Streptococcus pneumoniae or Hemophilus influenza,e or its partial efficacy
against Staphylococcus species or Enterobacteriacae. Consequently, in the
absence of full and durable recovery following antibiotic
treatment, it would be important to repeat AFB testing [23] or
to use the MTB/RIF test (Mycobacterium tuberculosis (MTB) and
resistance to rifampin (RIF)) [24]. Indeed, this test is easy to use,
inexpensive and available in developing countries. It is possible
that M.tuberculosis would be easier to detect once the bacterial co-
infection has been treated, if indeed the latter was responsible for
AFB-negativity. Another strategy would be to use empirical
tuberculosis treatment in conjunction with antiviral therapy in a
subset of patients with advanced immuno-deficiency who are
living in very high TB burden communities [25].
Our study has several limitations. First, the number of
coinfected patients with AFB- negativity was relatively small.
Second, some clinical data, such as the interval between symptom
onset and hospitalization, the presence of fever on admission [22]
and the Karnofsky score were too unreliable for meaningful
analysis. Third, not all of our patients had three sputum smear
examinations. Finally, the lack of radiological controls at 21 days
rules out any analysis of the part played by tuberculosis in the
radiological anomalies observed in patients with intercurrent
infections.
One novel finding of this study is the association between
concomitant respiratory tract infection and negative sputum AFB,
particularly in Cambodia. This finding suggests repeating AFB
Table 2. Factors associated with sputum smear negativity by univariate and multivariate analysis.
Characteristics AFB+ AFB2 Univariate analysis Multivariate analysis
(n=110) (n=65) OR* (CI95%)P OR* (CI95%) P
N( % ) N( % ) ( p #0.25) (p#0.05)
General characteristics
Region
Africa (Senegal, CAR) 53 (48) 38 (58) 1 1
Asia (Cambodia) 57 (52) 27 (42) 0.7 (0.4–1.2) 0.21 0.6 (0.3–1.4) 0.24
Clinical characteristics
Dyspnea, Yes 63 (57) 43 (66) 1.5 (0.8–2.8) 0.25 2.5 (1.1–5.6) 0.031
Cough $21 days 62 (57) 28 (46) 0.6 (0.3–1.2) 0.15
More than one pathogen 12 (11) 15 (23) 2.5 (1.1–5.6) 0.035 2.8 (1.1–7.0) 0.033
Biological characteristics
CD4 (/mm
3)
.50 33 (30) 32 (49) 1 1
#50 65 (59) 25 (38) 0.4 (0.2–0.8) 0.007 0.4 (0.2–0.90) 0.028
Missing data 12 (11) 8 (12) 0.7 (0.3–1.9) 0.47
Radiological characteristics
Localized interstitial, Yes 12 (11) 18 (28) 3.1 (1.4–7) 0.006 3.1 (1.3–7.6) 0.014
Mediastinal adenopathies, Yes 61 (55) 26 (40) 0.5 (0.3–1) 0.049 0.4 (0.2–0.93) 0.031
Cavitation, Yes 18 (16) 2 (3) 0.2 (0.04–0.7) 0.017 0.1 (0.03–0.6) 0.012
Retraction, Yes 11 (10) 0 (0) 0.1 (0 –0.6) 0.007
*OR: Odds Ratio.
doi:10.1371/journal.pone.0021212.t002
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treatment is not followed by complete recovery of the respiratory
symptoms. In HIV-infected patients with a CD4 cell count below
50/mm
3 without an identified cause of pneumonia, systematic
AFB direct sputum examination is justified because of atypical
clinical features (without cavitation) and high pulmonary myco-
bacterial burden.
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